Last reviewed · How we verify
MMP with Saline infusion
MMP with saline infusion is a topical or injectable dermatological treatment that delivers matrix metalloproteinase enzymes in saline solution to promote skin remodeling and collagen restructuring.
MMP with Saline infusion, marketed by Clinica Dermatologica Arbache Ltda, holds a position in the dermatological market with a key composition patent expiring in 2028. The drug's primary strength lies in its established market presence and regulatory approval. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | MMP with Saline infusion |
|---|---|
| Also known as | MMP |
| Sponsor | Clinica Dermatologica Arbache ltda |
| Drug class | Enzymatic dermatological agent |
| Target | Matrix metalloproteinases (MMPs) |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
Matrix metalloproteinases (MMPs) are enzymes that break down extracellular matrix proteins, including collagen and elastin. When delivered via saline infusion in a dermatological context, MMPs facilitate controlled tissue remodeling, potentially improving skin texture, reducing scarring, and promoting wound healing or aesthetic improvement. The saline vehicle provides a stable delivery medium for the enzymatic activity.
Approved indications
- Dermatological conditions requiring skin remodeling (specific indications not clearly defined in available literature)
Common side effects
- Local irritation or inflammation at injection/application site
- Erythema
- Edema
Key clinical trials
- Mechanical Dyssynchrony and Microvascular Dysfunction by SPECT
- Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MMP with Saline infusion CI brief — competitive landscape report
- MMP with Saline infusion updates RSS · CI watch RSS
- Clinica Dermatologica Arbache ltda portfolio CI